ClinicalTrials.gov
public full text
Public Domain
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investigate the mechanism for sulfonylurea response.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans#1060840
- QANDLI DIABET 2-TURI RIVOJLANISHINING MOLEKULYAR-GENETIK XAVF OMILLARI#144786
- A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes#847870
- A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice#866428
- Long-term Study of TAK-875#854032
Record · ID 1373102
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive